CS
Carol L. Shields
Highly rated in
47
conditions

Dr. Carol L. Shields

Wills Eye Hospital
Philadelphia, PA
Highly rated in
47
conditions
Specialties:Ophthalmology
Experience:40 Years
Clinical Trials:Currently Recruiting for 2 Trials
Accepts:New PatientsMedicare
Highly rated in
47
conditions
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Carol L. Shields' experience treating your condition:
About Dr. Carol L. Shields

Carol Shields is an Ophthalmologist in Philadelphia, Pennsylvania. Shields has been practicing medicine for over 40 years and is highly rated in 47 conditions, according to our data. Her top areas of expertise are Melanoma of the Eye, Retinoblastoma, Coats Disease, Cataract Removal, and Tissue Biopsy. She is licensed to treat patients in Pennsylvania. Shields is currently accepting new patients.

Her clinical research consists of co-authoring 838 peer reviewed articles and participating in 7 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Carol L. Shields it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Dr. Carol L. Shields accepts the following insurance:

  •  CareFirst
Locations
840 Walnut St, #1440, Philadelphia, PA 19107
Background & Education
Graduate Institution
University Of Pittsburgh School Of Medicine, 1983
Specialties
Ophthalmology
Licenses
Ophthalmology in PA
Hospital Affiliations
Thomas Jefferson University Hospital
St Mary Medical Center
Wills Eye Hospital
Languages Spoken
English
Arabic
Sign Language
Spanish
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials
A Registry of Patients With Primary Indeterminate Lesions or Choroidal Melanoma
Enrollment Status: Recruiting
Publish Date: December 08, 2022
A Phase 2 Open-label, Ascending Single and Repeat Dose Escalation Trial of Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma
Enrollment Status: Recruiting
Publish Date: December 02, 2022
Intervention Type: Device, Drug
Study Drug: AU-011
Study Phase: Phase 2
A Randomized Phase ll Study of Adjuvant Sunitinib or Valproic Acid in High-Risk Patients With Uveal Melanoma
Enrollment Status: Active, not recruiting
Publish Date: August 16, 2022
Intervention Type: Drug
Study Drugs: SunitinibValproic Acid
Study Phase: Phase 2
Intra-arterial (Ophthalmic Artery) Chemotherapy for Retinoblastoma
Enrollment Status: Completed
Publish Date: December 12, 2016
Intervention Type: Drug
Study Phase: Not Applicable
In Vivo Confocal Microscopy Study of Pigmented Conjunctival Lesions
Enrollment Status: Terminated
Publish Date: August 15, 2016
Intervention Type: Procedure
A Randomized Control Trial of Intravitreal Ranibizumab (Lucentis) for the Prevention of Radiation Maculopathy Following Plaque Radiotherapy for Choroidal Melanoma
Enrollment Status: Unknown status
Publish Date: October 08, 2007
Intervention Type: Drug
Study Drug: Ranibizumab
Study Phase: Phase 4
Sub-Tenon Triamcinolone in the Prevention of Radiation-Induced Macular Edema Following Plaque Radiotherapy for Uveal Melanoma
Enrollment Status: Completed
Publish Date: March 01, 2007
Intervention Type: Drug
Study Phase: Not Applicable
View 5 Less Clinical Trials -
838 Total Publications
Relationship between Fitzpatrick Skin Type and The Cancer Genome Atlas Classification with Melanoma-Related Metastasis and Death in 854 Patients at a Single Ocular Oncology Center.
Journal: Ophthalmic genetics
Published: November 12, 2022
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
TA
Dr. Tomas S. Aleman
Ophthalmology
Highly rated in
20
conditions
Ophthalmology

Penn Medicine

Penn Presbyterian Medical Center

51 N 39th St, 
Philadelphia, PA 
 2.4 mi

Tomas Aleman is an Ophthalmologist in Philadelphia, Pennsylvania. Aleman has been practicing medicine for over 35 years and is highly rated in 20 conditions, according to our data. His top areas of expertise are Choroideremia, Leber Congenital Amaurosis, Cone Dystrophy, and Retinitis Pigmentosa. He is licensed to treat patients in Pennsylvania. Aleman is currently accepting new patients.

BL
Dr. Bart P. Leroy
Ophthalmology
Highly rated in
21
conditions
Ophthalmology

34th & Civic Center Blvd, 
Philadelphia, PA 
 2.1 mi

Bart Leroy is an Ophthalmologist in Philadelphia, Pennsylvania. Leroy has been practicing medicine for over 31 years and is highly rated in 21 conditions, according to our data. His top areas of expertise are Leber Congenital Amaurosis, Late-Onset Retinal Degeneration, Retinitis Pigmentosa, Retinopathy Pigmentary Mental Retardation, and Cataract Removal. He is licensed to treat patients in Pennsylvania. Leroy is currently accepting new patients.

AH
Dr. Allen C. Ho
Ophthalmology
Highly rated in
18
conditions
Ophthalmology

Main Line Health

Wills Eye Hospital

840 Walnut St, 
Philadelphia, PA 

Allen Ho is an Ophthalmologist in Philadelphia, Pennsylvania. Ho has been practicing medicine for over 35 years and is highly rated in 18 conditions, according to our data. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Vein Occlusion, Cataract Removal, and Corneal Transplant. He is licensed to treat patients in New Jersey and Pennsylvania. Ho is currently accepting new patients.